Concentrations of nicotine that settle on surfaces, also called thirdhand smoke, as well as electronic cigarette spills can damage the skin.

According to a new study, the prevalence of keratosis pilaris is low in patients with atopic dermatitis.

Tildrakizumab treatment for psoriasis showed a significant improvement when used for difficult-to-treat areas.

Depressive symptoms are closely linked to AD severity and can fluctuate alongside AD severity.

Dupilumab shows safety and efficacy for up to four years in treatment of moderate-to-severe atopic dermatitis in adults.

Patients with psoriasis are at an increased risk of developing alopecia areata.

Microbotox is effective in treating mild-to-moderate acne vulgaris and erythematotelangiectatic rosacea, according to a new study.

Patients with AD are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus vs dupilumab alone.